Metformin Hydrochloride Tablet, Coated
NDC Package 83301-0010-2
Package Information
Metformin Hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. This formulation utilizes a tablet, coated delivery system. Marketed by Mullan Pharmaceutical Inc., this product is identified by NDC 83301-0010 and is authorized under FDA application ANDA205096.
Identification & Billing
- RxCUI: 861004 - metFORMIN HCl 1000 MG Oral Tablet
- RxCUI: 861004 - metformin hydrochloride 1000 MG Oral Tablet
- RxCUI: 861004 - metformin HCl 1 GM Oral Tablet
- RxCUI: 861007 - metFORMIN HCl 500 MG Oral Tablet
- RxCUI: 861007 - metformin hydrochloride 500 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83301 - Mullan Pharmaceutical Inc.
- 83301-0010 - Metformin Hydrochloride
- 83301-0010-2 - 500 TABLET, COATED in 1 BOTTLE
- 83301-0010 - Metformin Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (83301-0010). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83301-0010-2 identifies a specific commercial package of 500 tablet, coated in 1 bottle of Metformin Hydrochloride, a human prescription drug labeled by Mullan Pharmaceutical Inc.. This tablet, coated is formulated for oral use and contains metformin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mullan Pharmaceutical Inc. on January 01, 2024. The current certification is valid through December 31, 2026.
How is this Mullan Pharmaceutical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83301001002. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.